Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: A 20‐year cohort study of 3.8 million vaccinees
Yin‐Chu Chien, Chyi‐Feng Jan, Chun‐Ju Chiang, Hsu‐Sung Kuo, San‐Lin You, Chien‐Jen Chen – 4 February 2014 – Hepatitis B immunization has been documented to prevent fulminant hepatic failure (FHF) and hepatocellular carcinoma (HCC) by historical comparison studies in Taiwan. This study aimed to assess long‐term risks and predictors of various liver diseases associated with incomplete immunization in 3.8 million vaccinees.